Search results
Results from the WOW.Com Content Network
Memorial Sloan Kettering Cancer Center (MSK or MSKCC) is a cancer treatment and research institution in Manhattan in New York City. MSKCC is one of 72 National Cancer Institute–designated Comprehensive Cancer Centers. [3] [4] Its main campus is located at 1275 York Avenue between 67th and 68th Streets in Manhattan.
Memorial Sloan Kettering Cancer Center (also called Sloan Kettering, MSK, or MSKCC) is a cancer treatment and research institution in New York City. This page lists projects which individuals at Sloan Kettering have done in collaboration with the Wikipedia community.
Thousands of Memorial Sloan Kettering cancer patients could lose access to life-saving treatments in 2025 because of an ongoing contract fight with insurance giant Anthem Blue Cross Blue Shield.
Selwyn Maurice Vickers is an American gastrointestinal surgical oncologist. He serves as President and CEO of Memorial Sloan Kettering Cancer Center.Previously, Dr. Vickers was the senior vice president for Medicine and Dean of the University of Alabama at Birmingham School of Medicine and the CEO of both the UAB Health System and the UAB/Ascension St. Vincent's Alliance.
Joan Massagué (born April 30, 1953), is a Spanish biologist [1] and the current director of the Sloan Kettering Institute at Memorial Sloan Kettering Cancer Center.He is also an internationally recognized leader in the study of both cancer metastasis and growth factors that regulate cell behavior, as well as a professor at the Weill Cornell Graduate School of Medical Sciences.
Cycle for Survival is a nationwide (US) movement to beat rare cancers, owned and operated by Memorial Sloan Kettering Cancer Center (MSK). [1] Since its inception in 2007, Cycle for Survival—with support from its founding partner Equinox Fitness—has raised more than $208 million as of 2019.
Malcolm A. S. Moore (born January 18, 1944) is a British American biologist who is the Enid A. Haupt Chair of Cell Biology at the Memorial Sloan-Kettering Cancer Center. Moore is an oncologist and hematologist known for being the principal investigator in the development of filgrastim. He is a member of various national and international ...
The country's top doctor wants a new warning added to alcohol that would alert drinkers about links to cancer, but don't expect cigarette-style warning labels any time soon.. U.S. Surgeon General ...